LYUDMILA MAGAKYAN-MARTINEZ: Open Payments
NPI 1255757134 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 94 payments from 17 companies in 2025. Trend: 2023 $270 · 2024 $344 · 2025 $1,285
Food & beverage: $1,087Education: $199
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 29 | $309 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $236 |
| LEO Pharma Inc. | 15 | $179 |
| ABBVIE INC. | 17 | $176 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| GENZYME CORPORATION | 4 | $71 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Janssen Biotech, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $19 |
| Botanix SB Inc | 1 | $18 |
Products named: CIBINQO, DUPIXENT, ADBRY, ILUMYA, SKYRIZI, LITFULO, RINVOQ, TREMFYA.
Industry payments across NY — which companies pay providers there.
